Great Valley Advisor Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Great Valley Advisor Group's NVS Position: Q2 2026 in Review
Great Valley Advisor Group increased its Novartis (NVS) stake by 5.9% in Q2 2026, buying an estimated $181K and bringing the position to 21,792 shares worth $3.42M. The position accounts for 0.05% of the portfolio, ranked #293.
Great Valley Advisor Group first reported a position in NVS in Q3 2021 and has held it in 16 quarters since. The position peaked at $6.3M in Q2 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Great Valley Advisor Group held 21,792 shares of Novartis worth $3.42M as of Q2 2026.
- Great Valley Advisor Group bought 1,210 Novartis shares in Q2 2026, an estimated $181K.
- Novartis made up 0.05% of Great Valley Advisor Group's portfolio in Q2 2026, its #293 holding.
- Great Valley Advisor Group first reported a position in Novartis in Q3 2021 and has held it in 16 quarters since.
- Great Valley Advisor Group's Novartis position peaked at $6.3M in Q2 2025.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.